Adial Pharmaceuticals Inc (NASDAQ: ADIL)
$1.0150
-0.0050 ( -1.46% ) 64.9K
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
Market Data
Open
$1.0150
Previous close
$1.0200
Volume
64.9K
Market cap
$6.60M
Day range
$0.9950 - $1.0700
52 week range
$0.7650 - $4.1699
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 41 | Jan 13, 2025 |
| 8-k | 8K-related | 34 | Jan 08, 2025 |
| 424b3 | Other | 3 | Dec 31, 2024 |
| effect | Other | 1 | Dec 30, 2024 |
| s-1 | Registration statements | 7 | Dec 20, 2024 |
| 8-k | 8K-related | 15 | Dec 18, 2024 |
| s-8 | Registration statements | 5 | Dec 12, 2024 |
| 8-k | 8K-related | 14 | Dec 06, 2024 |
| 4 | Insider transactions | 1 | Dec 05, 2024 |
| 4 | Insider transactions | 1 | Nov 18, 2024 |